## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 1.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($172.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. State Street Corp Has $9 Billion Holdings in Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251209T131806 | Neutral | Relevance: 99%
- State Street Corp significantly increased its stake in Texas Instruments, now holding 4.77% ownership valued at nearly $9 billion. Despite this, several analysts have trimmed price targets, resulting in a consensus "Hold" rating for TXN with a target of $191.67. Texas Instruments also raised its quarterly dividend, offering a 3.1% yield, though its payout ratio is currently high at 103.8%.

**2. Intel, AMD, Texas Instruments Sued Over Chips Found in Russian Missiles**
- Source: marketscreener.com | 20251210T201100 | Neutral | Relevance: 99%
-  Intel, AMD, and Texas Instruments are reportedly being sued over the alleged discovery of their chips in Russian missiles. The article, however, seems to heavily gate content for members only, preventing full disclosure of the lawsuit details. Intel's company profile and recent news are also provided, including an EU antitrust fine reduction.

**3. Texas Instruments Incorporated $TXN Shares Bought by Sirios Capital Management L P**
- Source: MarketBeat | 20251210T125423 | Somewhat-Bullish | Relevance: 99%
-  Sirios Capital Management L P increased its stake in Texas Instruments Incorporated (NASDAQ:TXN) by 53.0% in Q2, making it the 15th largest holding in their portfolio. Other institutional investors have also modified their positions in the semiconductor company, while two insiders sold shares in November. Analysts have a consensus "Hold" rating on TXN with a price target of $191.67, and the company recently increased its quarterly dividend.

**4. The Manufacturers Life Insurance Company Sells 113,958 Shares of Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251211T140832 | Neutral | Relevance: 98%
-  The Manufacturers Life Insurance Company reduced its stake in Texas Instruments (NASDAQ:TXN) by 3.4% during the second quarter, selling 113,958 shares and now owning 3,240,855 shares valued at approximately $672.9 million. This adjustment occurred as Texas Instruments reported solid earnings with $1.48 EPS, revenue of $4.74 billion, and increased its quarterly dividend to $1.42. Institutional investors collectively own 84.99% of the company's stock, even as some insiders have recently sold shares.

**5. Ukrainians file lawsuits against Intel, AMD and Texas Instruments: report (AMD:NASDAQ)**
- Source: Seeking Alpha | 20251210T163028 | Neutral | Relevance: 98%
-  A Texas trial lawyer has initiated multiple lawsuits against major semiconductor companies, including Intel, AMD, and Texas Instruments. The legal actions allege that technology from these companies was discovered in Russian weaponry deployed against Ukrainian civilians. The suits were filed by attorney Mikal Watts of the Watts Law Firm.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($0.58M) |
| Sells | 4 ($0.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Forward P/E 29.6x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $165.2B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 29.6 |
| Current P/E | 33.1 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 5.4% to 1.6% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram positive (2.07), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.61% (CS: 56) | Neutral |
| RSI_14 | 65.5 | Neutral |
| MACD Histogram | 2.07 | Bullish |
| vs SMA20 | 1.077x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 0.998x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $181.67
- **Stop Loss:** $172.15 (5.2% risk)
- **Target:** $191.19 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 144
- **Position Value:** $26,160.48
- **Portfolio %:** 26.16%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*